openPR Logo
Press release

North America Is The Leading Market For Point-Of-Care Infectious Disease Diagnostics Products

03-30-2018 09:35 AM CET | Health & Medicine

Press release from: Clinical Diagnostic Market Report

North America Is The Leading Market For Point-Of-Care

Advancements in molecular diagnostics coupled with miniaturization of devices to drive the point-of-care infectious disease diagnostics market

Advancements in technological molecular diagnostics has boosted adoption of point-of-care solutions. The industry is also expected to grow with changing lifestyle. Currently, over 60% of population uses mobile phone. As a result, whole healthcare system has changed wherein portable devices has taken a key place.

Furthermore, growing preference for personalized medicine would create lucrative opportunity for point-of-care testing market in the near future.

Point-of-Care Infectious Disease Diagnostics Market Taxonomy:

Coherent Market Insights has segmented the point-of-care infectious disease diagnostics products market by

Therapeutic application
End Users
On the basis of type of diseases, the Global POC Infectious Disease Diagnostics market can be segmented as follows:

On the basis of end user, the Global POC Infectious Disease Diagnostics market can be segmented as follows:

North America is the leading market for point-of-care infectious disease diagnostics products

Get The Holistic SAMPLE With Research Methodology:

On the basis of geography, the point-of-care infectious disease diagnostics market can be segmented into four major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America holds a leading position in the market, followed by Europe. The prime factors responsible for growth of POC infectious disease diagnostics market in these regions are rapidly increasing prevalence of infectious diseases and growing demand for rapid and accurate test results. According to the National Ambulatory Medical Care Survey, the number of visits to physician offices for infectious and parasitic diseases was recorded to be around 23.6 million in 2010. However, the market in Asia Pacific is expected to grow at the highest CAGR during the forecast period, due to presence of a large population base. The factors which would accentuate growth of point-of-care infectious disease diagnostics industry in Asia Pacific are increased government funding towards development of point-of-care diagnostic kits and rapidly changing healthcare infrastructure in emerging countries such as China, India, Vietnam, Malaysia, and Indonesia. Also, reduction in number of hospital bed required, reduction in number of outpatient clinic visits, and lesser patient waiting times are few of the potential factors that would propel growth in adoption of point-of-care infectious disease diagnostics in Asia Pacific during the forecast period.

Abbott Laboratories, Roche Diagnostics Ltd are driving market expansion through high R&D spending along with direct distribution channel in emerging economies

The point-of-care infectious disease diagnostics market is driven by technological advancements and hence, various companies are continuously making efforts to develop novel products pertaining to infectious disease diagnostics. Some of the top companies operating in the POC infectious disease diagnostics market are Abbott Laboratories, Roche Diagnostics Ltd., Beckman Coulter, Inc., Bayer AG, Becton Dickinson and Company, Johnson and Johnson, Alere Inc., Nipro Diagnostics Inc., Nova Biomedical, Siemens AG, Trinity Biotech PLC, Danaher Corporation, and Spectral Diagnostics.

Point-of-care infectious disease diagnostics market has grown manifold over the last 20 years, driving major profits across value chains. The industry witnessed slow growth during 2005–2010 before taking a major leap with adoption of mobile technology. Point-of-care testing or bed-side testing refers to tests that are performed near the site of patient care. These tests can potentially improve detection and management of infectious diseases by reducing time between tests and results. These testing aids in reduction of operating times, postoperative care time, and high-dependency, thereby ensuring optimal use of professional time. Urine test strips and imaging tests such as portable ultrasound and ECG tests are some examples of point-of-care testing. Point-of-care testing for infectious diseases includes rapid, reliable, and affordable tests for HIV infection, malaria, dengue fever, hepatitis, influenza, and pneumonia. Point-of-testing for infectious diseases exhibit a major opportunity for pharmacy services for expansion. Improvement in disease outcomes, simple and accurate tests, and rapid disease outcome and results are few of the advantages of point-of-care testing.

The billion dollar point-of-care infectious disease diagnostic market is expected to grow at a substantial rate over the forecast period (2016–2024).

Get Table Of Content:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit our news Website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Is The Leading Market For Point-Of-Care Infectious Disease Diagnostics Products here

News-ID: 998897 • Views: 598

More Releases from Clinical Diagnostic Market Report

Women’s Health Diagnostic Test Market - By Application Ovarian Cancer Test, Br …
In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in the U.S. This program is expected to create awareness of CVD related diseases among women and also help to improve lifestyle. Download The PDF Brochure:
Non-Invasive Cancer Diagnostics Market- Trends And Outlook
Non-invasive cancer diagnostics are procedures used for the identification of cancer without incision in the body. Detection and treatment of cancer at early stages are important for long-term survival. Non-invasive cancer detection method is found to be an increasing choice of interest, owing to its painless or minimal pain method of diagnostic coupled with more accurate results. Molecular based diagnostic methods are expected to increase during the forecast period due
Molecular Diagnostics Market - Global Industry Insights
Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA, which may be associated with disease. The disturbance between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others factors lead to various diseases. Disease that are diagnosed by using molecular diagnostic test includes infectious diseases, oncology, virology, and STDs. Increasing incidence and prevalence of infectious disease and cancer is expected to be a major factor
Autoimmune Disease Diagnostics Market - Global Industry Insights, Trends, 2017 …
The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the

All 5 Releases

More Releases for Diagnostics

Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025. The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. Get Free Sample PDF Copy at Top Key Players in the Global Covid-19 Diagnostic Market Include: - o Abbott Diagnostics o
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer
05-16-2019 | Health & Medicine
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report. Get Sample Copy of this Report @